共 111 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2019)Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors Prz Gastroenterol 14 89-103
[3]
Soerjomataram I(1989)Surgical adjuvant therapy of largebowel carcinoma : an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic J Clin Oncol 7 1447-1456
[4]
Rawla P(1990)Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 352-358
[5]
Sunkara T(1995)Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma : a final report Ann Intern Med 122 321-326
[6]
Barsouk A(2004)Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer N Engl J Med 350 2343-2351
[7]
Laurie JA(2015)Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial J Clin Oncol 33 3733-3740
[8]
Moertel CG(2007)Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07 J Clin Oncol 25 2198-2204
[9]
Fleming TR(2017)Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer PLoS One 12 e0176745-3116
[10]
Moertel CG(2009)Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adju-vant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 3109-20